Usana Health Sciences/$USNA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Usana Health Sciences
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
Ticker
$USNA
Sector
Primary listing
NYSE
Employees
1,700
Headquarters
Website
USNA Metrics
BasicAdvanced
$551M
16.82
$1.79
0.64
-
Price and volume
Market cap
$551M
Beta
0.64
52-week high
$40.58
52-week low
$23.10
Average daily volume
113K
Financial strength
Current ratio
2.153
Quick ratio
1.244
Interest coverage (TTM)
66.27%
Profitability
EBITDA (TTM)
79.85
Gross margin (TTM)
79.93%
Net profit margin (TTM)
3.79%
Operating margin (TTM)
6.25%
Effective tax rate (TTM)
46.09%
Revenue per employee (TTM)
$530,000
Management effectiveness
Return on assets (TTM)
5.14%
Return on equity (TTM)
6.34%
Valuation
Price to earnings (TTM)
16.818
Price to revenue (TTM)
0.635
Price to book
1.05
Price to tangible book (TTM)
2.29
Price to free cash flow (TTM)
11.206
Free cash flow yield (TTM)
8.92%
Free cash flow per share (TTM)
2.693
Growth
Revenue change (TTM)
2.75%
Earnings per share change (TTM)
-37.19%
3-year revenue growth (CAGR)
-5.89%
10-year revenue growth (CAGR)
0.30%
3-year earnings per share growth (CAGR)
-26.69%
10-year earnings per share growth (CAGR)
-5.84%
What the Analysts think about USNA
Analyst ratings (Buy, Hold, Sell) for Usana Health Sciences stock.
Bulls say / Bears say
Q2 2025 net sales rose 11% YoY to $236 million, surpassing the $225.2 million analyst consensus and driving a 14% after-hours stock rally. (Investing.com)
Adjusted diluted EPS jumped 36% YoY to $0.74, well above the $0.54 analyst estimate, underscoring improved profitability. (Investing.com)
USANA ended Q2 2025 with $151 million in cash, zero debt, and repurchased 528,000 shares for $15 million, underscoring strong balance-sheet health and shareholder returns. (Nasdaq)
GAAP net earnings fell 43.8% in Q1 2025 to $9.4 million from $16.5 million and declined 7% in Q2 2025 to $9.7 million, highlighting ongoing margin pressures. (Investing.com)(Business Wire)
Direct selling Active Customers dropped to 459,000 in Q1 2025 from 494,000 a year earlier and to 418,000 in Q2 2025 from 468,000, suggesting challenges in customer engagement. (Business Wire)(Business Wire)
Q2 2025 net sales in Asia Pacific fell 4% YoY to $163 million and in Americas & Europe declined 8% to $39 million, indicating regional headwinds. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2025.
USNA Financial Performance
Revenues and expenses
USNA Earnings Performance
Company profitability
USNA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Usana Health Sciences stock?
Usana Health Sciences (USNA) has a market cap of $551M as of September 18, 2025.
What is the P/E ratio for Usana Health Sciences stock?
The price to earnings (P/E) ratio for Usana Health Sciences (USNA) stock is 16.82 as of September 18, 2025.
Does Usana Health Sciences stock pay dividends?
No, Usana Health Sciences (USNA) stock does not pay dividends to its shareholders as of September 18, 2025.
When is the next Usana Health Sciences dividend payment date?
Usana Health Sciences (USNA) stock does not pay dividends to its shareholders.
What is the beta indicator for Usana Health Sciences?
Usana Health Sciences (USNA) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.